[
    "{\"step_by_step_thinking\": \"The patient has a history of STEMI, hypertension, and peripheral vascular disease. His current symptoms of jugular venous distention and bilateral lower extremity pitting edema suggest heart failure. Beta-blockers and ACE inhibitors are both recommended for patients with heart failure and post-MI. However, among the options, metoprolol succinate and atenolol are beta-blockers, while lisinopril is an ACE inhibitor, and propranolol is a non-selective beta-blocker. Metoprolol succinate is a long-acting, cardioselective beta-blocker that has been shown to reduce mortality in patients with heart failure and post-MI, while atenolol has not been shown to reduce mortality in heart failure. Lisinopril, an ACE inhibitor, also reduces mortality in heart failure and post-MI, but the question asks for the greatest mortality benefit, and beta-blockers have been shown to have a slightly greater mortality benefit than ACE inhibitors in these patients.\", \"answer_choice\": \"C. Metoprolol succinate\"}"
]